Request Sample Inquiry
Targeted Therapeutics Market

Targeted Therapeutics Market

Targeted Therapeutics Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

146

Base Year:

2022

Date

Sep - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2277

Segments Covered
  • By Type By Type Monoclonal Antibodies, Small Molecules
  • By Application By Application Breast Cancer, Colorectal Cancer, Lung Cancer, Multiple Sclerosis, Renal Cancer, Other Applications
  • By Distribution Channel By Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 68.1 Billion
Revenue 2030Revenue 2030: USD 80.9 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 2.5%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Targeted Therapeutics Market - Segment Analysis
    1. Overview
    2. Global Targeted Therapeutics Market, 2016 - 2028 (USD Million)
    3. Global Targeted Therapeutics Market - by Type
      1. By Monoclonal Antibodies
      2. By Small Molecules
    4. Global Targeted Therapeutics Market - by Application
      1. By Breast Cancer
      2. By Colorectal Cancer
      3. By Lung Cancer
      4. By Multiple Sclerosis
      5. By Renal Cancer
      6. By Other Applications
    5. Global Targeted Therapeutics Market - by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Global Targeted Therapeutics Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Targeted Therapeutics Market - Segment Analysis
    1. Overview
    2. North America Targeted Therapeutics Market, 2016 - 2028 (USD Million)
    3. North America Targeted Therapeutics Market, by Type
      1. By Monoclonal Antibodies
      2. By Small Molecules
    4. North America Targeted Therapeutics Market, by Application
      1. By Breast Cancer
      2. By Colorectal Cancer
      3. By Lung Cancer
      4. By Multiple Sclerosis
      5. By Renal Cancer
      6. By Other Applications
    5. North America Targeted Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. North America Targeted Therapeutics Market, by Country
      1. U.S.
        1. U.S. Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. U.S. Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. U.S. Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Canada
        1. Canada Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Canada Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Canada Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Mexico
        1. Mexico Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Mexico Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Mexico Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  5. Europe Targeted Therapeutics Market - Segment Analysis
    1. Overview
    2. Europe Targeted Therapeutics Market, 2016 - 2028 (USD Million)
    3. Europe Targeted Therapeutics Market, by Type
      1. By Monoclonal Antibodies
      2. By Small Molecules
    4. Europe Targeted Therapeutics Market, by Application
      1. By Breast Cancer
      2. By Colorectal Cancer
      3. By Lung Cancer
      4. By Multiple Sclerosis
      5. By Renal Cancer
      6. By Other Applications
    5. Europe Targeted Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Europe Targeted Therapeutics Market, by Country
      1. Germany
        1. Germany Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Germany Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Germany Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. UK
        1. UK Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. UK Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. UK Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. France
        1. France Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. France Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. France Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      4. Spain
        1. Spain Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Spain Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Spain Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      5. Italy
        1. Italy Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Italy Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Italy Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      6. BENELUX
        1. BENELUX Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. BENELUX Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. BENELUX Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      7. Rest of Europe
        1. Rest Of Europe Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Rest Of Europe Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Rest Of Europe Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  6. Asia Pacific Targeted Therapeutics Market - Segment Analysis
    1. Overview
    2. Asia Pacific Targeted Therapeutics Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Targeted Therapeutics Market, by Type
      1. By Monoclonal Antibodies
      2. By Small Molecules
    4. Asia Pacific Targeted Therapeutics Market, by Application
      1. By Breast Cancer
      2. By Colorectal Cancer
      3. By Lung Cancer
      4. By Multiple Sclerosis
      5. By Renal Cancer
      6. By Other Applications
    5. Asia Pacific Targeted Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Asia Pacific Targeted Therapeutics Market, by Country
      1. China
        1. China Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. China Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. China Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Japan
        1. Japan Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Japan Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Japan Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. India
        1. India Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. India Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. India Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      4. South Korea
        1. South Korea Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. South Korea Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. South Korea Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      5. South East Asia
        1. South East Asia Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. South East Asia Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. South East Asia Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Rest of Asia Pacific Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Rest of Asia Pacific Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  7. Latin America Targeted Therapeutics Market - Segment Analysis
    1. Overview
    2. Latin America Targeted Therapeutics Market, 2016 - 2028 (USD Million)
    3. Latin America Targeted Therapeutics Market, by Type
      1. By Monoclonal Antibodies
      2. By Small Molecules
    4. Latin America Targeted Therapeutics Market, by Application
      1. By Breast Cancer
      2. By Colorectal Cancer
      3. By Lung Cancer
      4. By Multiple Sclerosis
      5. By Renal Cancer
      6. By Other Applications
    5. Latin America Targeted Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Latin America Targeted Therapeutics Market, by Country
      1. Brazil
        1. Brazil Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Brazil Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Brazil Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. Argentina
        1. Argentina Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Argentina Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Argentina Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Rest of Latin America
        1. Rest of Latin America Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Rest of Latin America Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Rest of Latin America Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  8. Middle East & Africa Targeted Therapeutics Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Targeted Therapeutics Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Targeted Therapeutics Market, by Type
      1. By Monoclonal Antibodies
      2. By Small Molecules
    4. Middle East & Africa Targeted Therapeutics Market, by Application
      1. By Breast Cancer
      2. By Colorectal Cancer
      3. By Lung Cancer
      4. By Multiple Sclerosis
      5. By Renal Cancer
      6. By Other Applications
    5. Middle East & Africa Targeted Therapeutics Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail Pharmacies
      3. By Online Pharmacies
    6. Middle East & Africa Targeted Therapeutics Market, by Country
      1. GCC Countries
        1. GCC Countries Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. GCC Countries Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. GCC Countries Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      2. South Africa
        1. South Africa Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. South Africa Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. South Africa Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Targeted Therapeutics Market, By Type
          1. By Monoclonal Antibodies
          2. By Small Molecules
        2. Rest of Middle East & Africa Targeted Therapeutics Market, By Application
          1. By Breast Cancer
          2. By Colorectal Cancer
          3. By Lung Cancer
          4. By Multiple Sclerosis
          5. By Renal Cancer
          6. By Other Applications
        3. Rest of Middle East & Africa Targeted Therapeutics Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail Pharmacies
          3. By Online Pharmacies
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Agenus Inc. (U.S.)
    2. Aurinia Pharmaceuticals Inc. (Canada)
    3. Celdara Medical LLC (U.S.)
    4. Pfizer Inc. (U.S.)
    5. Gilead Sciences Inc. (U.S.)
    6. Nektar Therapeutics Inc. (U.S.)
    7. F. Hoffmann-La Roche & Co. (Switzerland)
    8. Amgen Inc. (U.S.)
    9. Serena Therapeutics Inc. (U.S.)
    10. AstraZeneca PLC (UK)
    11. Arcus Biosciences Inc. (U.S.)
    12. Genentech Inc. (U.S.)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 11-Sep-2023
Targeted Therapeutics Market to Reach Valuation of USD 80.9 Billion by 2030 – Growing Demand for More Effective and Personalized Treatment Options Drives the Market Growth
FAQ
Frequently Asked Question

  • The global Targeted Therapeutics valued at USD 68.1 Billion in 2022 and is expected to reach USD 80.9 Billion in 2030 growing at a CAGR of 2.5%.

  • The prominent players in the market are Agenus Inc. (U.S.), Aurinia Pharmaceuticals Inc. (Canada), Celdara Medical LLC (U.S.), Pfizer Inc. (U.S.), Gilead Sciences Inc. (U.S.), Nektar Therapeutics Inc. (U.S.), F. Hoffmann-La Roche & Co. (Switzerland), Amgen Inc. (U.S.), Serena Therapeutics Inc. (U.S.), AstraZeneca PLC (UK), Arcus Biosciences Inc. (U.S.), Genentech Inc. (U.S.).

  • The market is project to grow at a CAGR of 2.5% between 2023 and 2030.

  • The driving factors of the Targeted Therapeutics include

    • Increasing Prevalence of Various Type of Cancers

  • North America was the leading regional segment of the Targeted Therapeutics in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy